arrow
E

Eva Serrano-Candelas

protoqsar sl
H指数:14
被引数:833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overcoming difficult, impossible, and meaningless animal testing under REACH: Opportunities for robust chemical risk assessment with non-animal approaches

克服REACH法规下的困难、不可能及无意义的动物测试:非动物方法在可靠化学风险评估中的机遇

2026-08-011
PRE
Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes

解析药物诱导的肝脂肪变性:临床亚表型、结局预测、高风险药物识别及有害化学属性鉴定

2025-08-150
PREAI
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support (vol 174, 116560, 2024)

药物引起的胆汁淤积症的新型临床表型,药物分类和结果预测: 通过文献综述和机器学习支持开发的432例患者数据库分析 (174卷,116560,2024)

2024-06-010
OAAI
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support

药物引起的胆汁淤积症的新型临床表型,药物分类和结果预测: 通过文献综述和机器学习支持开发的432例患者数据库分析

2024-05-011
OAAI